Gilead Sciences has become the first pharmaceutical company to set up a licensing agreement with the recently-established Medicines Patent Pool (MPP), in a move aimed toward increasing access in developing countries to drugs that treat HIV and Hepatitis B. The landmark deal was announced yesterday, 12 July.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/medicines-patent-pool-receives-first-licence-hiv-drugs-major-pharmaceutical-company
[2] http://ictsd.org/i/news/bridgesweekly/110421/
[3] http://admin.indiaenvironmentportal.org.in/category/journal/bridges-weekly-trade-news-digest
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/patents
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/aids
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/developing-countries
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
